REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastoma

Authors: Caccese, M., Desideri, I., Villani, V., Simonelli, M., Buglione, M., Chiesa, S., Franceschi, E., Gaviani, P., Stasi, I., Caserta, C., Brugnara, S., Lolli, I., Bennicelli, E., Bini, P., Cuccu, A.S., Scoccianti, S., Padovan, M., Gori, S., Bonetti, A., Giordano, P., Pellerino, A., Gregucci, F., Riva, N., Cinieri, S., Internò, V., Santoni, M., Pernice, G., Dealis, C., Stievano, L., Paiar, F., Magni, G., De Salvo, G.L., Zagonel, V., Lombardi, G.

Source: In ESMO Open April 2024 9(4)

P03.11.A Potential role of pre-radiotherapy MRI for target delineation in high-grade gliomas: a multicenter retro-prospective cohort study

Authors: Satragno, C, Gonnelli, A, Cella, E, Scaffidi, C, Ginulla, A, Tagliamento, M, Giannini, N, Gadducci, G, Valenti, S, Grassi, M, Giannelli, F, Bennicelli, E, Fiaschi, P, Truffelli, M, Delle Piane, C, Raffa, S, Morbelli, S, Roccatagliata, L, Schiavetti, I, Barletta, L, Castellan, L, Belgioia, L, Paiar, F, Barra, S

Source: Neuro-oncology. 24(Supplement 2):ii34-ii35

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100161236123.0x000001&indx=1&recIds=ETOCvdc_100161236123.0x000001

PO-1133 Potential role of pre-radiotherapy MRI for target delineation in high-grade gliomas

Authors: satragno, C., Gonnelli, A., Esposito, D., Ginulla, A., Scaffidi, C., Cella, E., Tagliamento, M., Giannini, N., Gadducci, G., Valenti, S., Giannelli, F., Fozza, A., Bennicelli, E., Fiaschi, P., Morbelli, S., Roccatagliata, L., Paiar, F., Barra, S., Belgioia, L.

Source: Radiotherapy and oncology. 182(S1):S906-S906

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100194853391.0x000001&indx=1&recIds=ETOCvdc_100194853391.0x000001

1897P Time to access to diagnosis and treatment for lung cancer (LC): Experience within an Italian comprehensive cancer center

Authors: Nardin, S., Barcellini, L., Sacco, G., Ferrante, M., Pollone, B.R., Lucente, L., Latocca, M.M., Dellepiane, C., Rossi, G., Bennicelli, E., Barletta, G., Zinoli, L., Cella, E., Coco, S., Santamaria, S., Marconi, S., Tagliamento, M., Lambertini, M., Del Mastro, L., Genova, C.

Source: In Annals of Oncology September 2024 35 Supplement 2:S1107-S1108

471P PTEN alteration as a predictor of second-line efficacy in patients with recurrent IDHwt-glioblastoma

Authors: Cella, E., Polano, M., Padovan, M., Bosio, A., Caccese, M., Corrà, M., Cerretti, G., Bennicelli, E., Toffoli, G., Lombardi, G.

Source: In Annals of Oncology September 2024 35 Supplement 2:S417-S417

461P Effectiveness of dabrafenib-trametinib and larotrectinib in adult recurrent glioblastoma patients: A real-life cohort analysis from 3 Italian centers

Authors: Padovan, M., Cella, E., Bosio, A., Maccari, M., Cerretti, G., Caccese, M., Corrà, M., Giordano, P., Bennicelli, E., Lombardi, G.

Source: In Annals of Oncology September 2024 35 Supplement 2:S414-S414

Two doses of NGR-hTNF in combination with capecitabine plus oxaliplatin in colorectal cancer patients failing standard therapies

Authors: Mammoliti, S., Andretta, V., Bennicelli, E., Caprioni, F., Comandini, D., Fornarini, G., Guglielmi, A., Pessino, A., Sciallero, S., Sobrero, A.F., Mazzola, G., Lambiase, A., Bordignon, C. ^*

Source: In Annals of Oncology April 2011 22(4):973-978

Chemotherapy: which drug and when?

Authors: Sobrero, A. ^*, Bennicelli, E.

Source: In Annals of Oncology October 2010 21 Supplement 7:vii130-vii133

Phase Ib study of NGR–hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours

Authors: Gregorc, V., Santoro, A., Bennicelli, E., Punt, C. J., Citterio, G., Timmer-Bonte, J. N., Caligaris Cappio, F., Lambiase, A., Bordignon, C., van Herpen, C. M.

Source: BRITISH JOURNAL OF CANCER. 101(2):219-224

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN254274718&indx=1&recIds=ETOCRN254274718

First-line single-agent cetuximab in patients with advanced colorectal cancer

Authors: Pessino, A., Artale, S., Sciallero, S., Guglielmi, A., Fornarini, G., Andreotti, I. C., Mammoliti, S., Comandini, D., Caprioni, F., Bennicelli, E.

Source: ANNALS OF ONCOLOGY. 19(4):711-716

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN226231776&indx=1&recIds=ETOCRN226231776

1456P Exploring biological and molecular factors as outcome predictors for pembrolizumab (Pem) or pembrolizumab-chemotherapy (Pem-CT) in advanced non-small cell lung cancer (NSCLC)

Authors: Zullo, L., Aldea, M., Paoloni, F., Rosa, A., Fontana, V., Cella, E., Soldato, D., Gualtieri, M., Spotti, M.P., Barletta, G., Dellepiane, C., Rossi, G., Bennicelli, E., Meyer, M-L., Parisi, C., Del Mastro, L., Planchard, D., Berardi, R., Besse, B., Genova, C.

Source: In Annals of Oncology October 2023 34 Supplement 2:S827-S828

507MO REGOMA-OS: A large Italian multicenter, prospective, observational study analyzing regorafenib efficacy and safety in recurrent glioblastoma patients

Authors: Lombardi, G., Desideri, I., Villani, V., Simonelli, M., Buglione, M., Chiesa, S., Franceschi, E., Gaviani, P., Stasi, I., Caserta, C., Brugnara, S., Lolli, I.R., Bennicelli, E., Bini, P., Cuccu, A., S. scoccianti, Magni, G., Caccese, M., De Salvo, G., Zagonel, V.

Source: In Annals of Oncology October 2023 34 Supplement 2:S395-S395

P16.13 MenImmune: Evaluation of immune-related and prognostic biomarkers in meningioma

Authors: Truffelli, M, Grassi, M, Fiaschi, P, Roccatagliata, L, Bennicelli, E, Barletta, L, Cella, E, Valle, L, Zona, G, Gaggero, G

Source: Neuro-oncology. 23(Supplement 2):ii58-ii58

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100165314221.0x000001&indx=1&recIds=ETOCvdc_100165314221.0x000001

P13.22 Menglia: an innovative approach to liquid biopsies in glioma patients

Authors: Truffelli, M, Petretto, A, Candiano, G, Giunti, D, Vigo, T, Gaggero, G, Bennicelli, E, Grassi, M, Zona, G, Fiaschi, P

Source: Neuro-oncology. 23(Supplement 2):ii37-ii37

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100165314157.0x000001&indx=1&recIds=ETOCvdc_100165314157.0x000001

66P Outcome predictors for pembrolizumab alone or with chemotherapy in advanced non-small cell lung cancer (NSCLC)

Authors: Zullo, L., Cella, E., Paoloni, F., Gualtieri, M., Barletta, G., Favero, D., Parisi, F., Dellepiane, C., Rossi, G., Bennicelli, E., Zinoli, L., Cantini, L., Pecci, F., Del Mastro, L., Berardi, R., Genova, C.

Source: In Journal of Thoracic Oncology April 2023 18(4) Supplement:S78-S79

EP08.01-088 Direct Acting Antivirals (DAA) and Immune Checkpoint Inhibitors (ICIs) Therapy in Patients with Lung Cancer and Hepatitis C

Authors: Tagliamento, M., Cella, E., Sacco, G., Rossi, G., Limongelli, A., Dellepiane, C., Brucci, G., Zullo, L., Parisi, F., Baldi, F., Bennicelli, E., Barletta, G., Coco, S., Marconi, S., Alama, A., Bozzano, F., Bello, M.G. Dal, Perrone, C., De Maria, A., Genova, C.

Source: In Journal of Thoracic Oncology September 2022 17(9) Supplement:S384-S385

1099P Front-line liquid biopsy for early molecular assessment and treatment of hospitalized lung cancer patients

Authors: Parisi, F., De Luca, G., Rossi, G., Coco, S., Dellepiane, C., Bennicelli, E., Zinoli, L., Zullo, L., Alama, A., Mosconi, M., Mora, M., Ballestrero, A., Montecucco, F., Marconi, S., Pronzato, P., Del Mastro, L., Nozza, P., Bellodi, A., Dono, M., Genova, C.

Source: In Annals of Oncology September 2022 33 Supplement 7:S1053-S1054

1043P Clinical predictors of benefit from pembrolizumab (pembro) or pembro-chemotherapy (CHT) in advanced non-small cell lung cancer (NSCLC)

Authors: Zullo, L., Cella, E., Favero, D., Parisi, F., Dellepiane, C., Rossi, G., Bennicelli, E., Barletta, G., Zinoli, L., Pronzato, P., Del Mastro, L., Genova, C.

Source: In Annals of Oncology September 2022 33 Supplement 7:S1031-S1031

293P Molecular biomarkers correlation in symptomatic tumor-related epilepsy: A preliminary study on 151 cases of brain tumors

Authors: Cella, E., Mambriani, S., Donniaquio, A., Hasanzadeh, F., P. Nozza, Bennicelli, E., Arnaldi, D.

Source: In Annals of Oncology September 2022 33 Supplement 7:S672-S673

A monocentric retrospective data from 2005-2008 in colon-rectal cancer: an analysis in clinical practice experience
17th National Congress of Medical Oncology

Authors: Cosentino, C., Traverso, E. S., Bennicelli, E., Carlotta, S.

Source: Annals of oncology. 26(LEMENT 6):vi50-vi51

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCCN602710073&indx=1&recIds=ETOCCN602710073